lowmemcpu
This is one of those multi-day, multi-faceted topics that need us to have many conversations until it's stopped.
Recall the SOPA & PIPA protests of last decade: https://en.wikipedia.org/wiki/Protests_against_SOPA_and_PIPA
There were more than a few discussions here
Europe’s 'Last Dictatorship'
I wonder why it was forced to shut down?
I bet a few of the graduates are on HN, so maybe someone has the backstory?
Nomnoml
Mylar: Experimental platform for web apps with end-to-end encryption (2014)
RoWrite 2 Smart Writing Notebook
Invest in Relationships
Large in-person classes you don't even have discussions. Some universities have lecture halls of 400-600 students, and you have to go ask a TA for help later in the week
> That's not dissimilar to the situation before the plague.
So I think you agree and are saying that it's the same?
The Inklings
I've seen this denial of service attack against SQL/Relational databases as well, and I imagine if it triggers more read replicas, that a large bill could be caused as well
so it's not unique to GraphQL
I must have missed that. Could you find that article for me?
Yes, Krebs' does his own research, but he also has hundreds of security researchers and contacts that provide him info, many of those are insiders. In his book Spam Nation, he even goes to Russia to visit a crime boss to ask tough questions. This isn't some cyberstalker.
Krebs is a better researcher than most, so I tend to trust his doxx. Most of the info he publishes is already public (poor opsec) and he is more thorogh than Reddit. Can he be wrong? Sure..... should he doxx? I don't know, that's an ethics question.. but if he's wrong on this, I'm sure Brian will reconsider that in the future
Build Boring Software
8 Lines of Code
The Update Framework
Humble Bundle: Raspberry Pi Books
The Year I Destroyed My Finances
With oil cheap, Arab states cannot balance their books
Did anyone find value in this? It comes off as a bit arrogant maybe, but maybe Ineed to reread it
Polygonal Planet Project
Designing a New Old Home: Part 2
"Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial"